2.815

0.30% -0.005

Nuvation Bio Inc (NUVB)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

$2.82

Offen:

$2.81

24-Stunden-Volumen:

745.60K

Relative Volume:

0.36

Marktkapitalisierung:

$944.07M

Einnahmen:

Nettoeinkommen (Verlust:

$-75.80M

KGV:

-6.8659

EPS:

-0.41

Netto-Cashflow:

$-68.07M

1W Leistung:

+4.52%

1M Leistung:

-2.72%

6M Leistung:

-5.97%

1J Leistung:

+87.43%

1-Tages-Spanne:

$2.73

$2.8363

1-Wochen-Bereich:

$2.57

$2.8363

52-Wochen-Spanne:

$1.43

$4.1598

Nuvation Bio Inc Stock (NUVB) Company Profile

Firmenname

Nuvation Bio Inc

Sektor

Healthcare (1187)

Branche

Biotechnology (668)

Telefon

(415) 754-3517

Adresse

357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO

Mitarbeiter

203

Twitter

Nächster Verdiensttermin

2024-11-04

Neueste SEC-Einreichungen

NUVB's Discussions on Twitter

Vergleichen Sie NUVB mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NUVB Nuvation Bio Inc	2.815	944.07M	0	-75.80M	-68.07M	-0.35
VRTX Vertex Pharmaceuticals Inc	409.60	105.21B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	715.84	78.48B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	634.65	37.55B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	241.57	31.19B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.88	27.43B	3.30B	-501.07M	1.03B	-2.1146

Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-03-27	Hochstufung	Jefferies	Hold → Buy
2024-03-26	Hochstufung	BTIG Research	Neutral → Buy
2023-01-06	Herabstufung	Jefferies	Buy → Hold
2022-08-02	Herabstufung	BMO Capital Markets	Outperform → Market Perform
2022-08-02	Herabstufung	BTIG Research	Buy → Neutral
2022-05-04	Eingeleitet	H.C. Wainwright	Buy
2021-10-15	Fortgesetzt	BTIG Research	Buy
2021-04-06	Eingeleitet	RBC Capital Mkts	Outperform
2021-03-08	Eingeleitet	BMO Capital Markets	Outperform
2021-03-08	Eingeleitet	BTIG Research	Buy
2021-03-08	Eingeleitet	Cowen	Outperform
2021-03-08	Eingeleitet	Jefferies	Buy
2021-03-08	Eingeleitet	Wedbush	Outperform

Alle ansehen

Nuvation Bio Inc Aktie (NUVB) Neueste Nachrichten

Dec 24, 2024

U.S. Food and Drug Administration Accepts for Priority Review Nuvation Bio’s New Drug Application for Taletrectinib for the Treatment of Advanced ROS1-positive Non-Small Cell Lung Cancer - BioSpace

Dec 23, 2024

FDA sets review date for Nuvation Bio's cancer drug - Investing.com

Dec 23, 2024

Dec 21, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 8,670 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World

Dec 21, 2024

Dec 20, 2024

Wellington Management Group LLP Purchases 283,642 Shares of Nuvation Bio Inc. (NYSE:NUVB) - MarketBeat

Dec 20, 2024

Dec 19, 2024

Nuvation Bio (NYSE:NUVB) Trading Up 5%Still a Buy? - MarketBeat

Dec 19, 2024

Dec 18, 2024

Verition Fund Management LLC Sells 13,409 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World

Dec 18, 2024

Dec 15, 2024

Charles Schwab Investment Management Inc. Increases Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World

Dec 15, 2024

Dec 13, 2024

Nuvation Bio's SWOT analysis: taletrectinib drives stock outlook amid pipeline shifts - Investing.com

Dec 13, 2024

Clear Street sets Nuvation Bio at Buy with $5 target By Investing.com - Investing.com South Africa

Dec 13, 2024

Clear Street sets Nuvation Bio at Buy with $5 target - Investing.com

Dec 13, 2024

Dec 12, 2024

Point72 Asset Management L.P. Takes Position in Nuvation Bio Inc. (NYSE:NUVB) - MarketBeat

Dec 12, 2024

Dec 10, 2024

Nuvation Bio Inc (NYSE: NUVB) Drops -1.75 Percent In Recent Session, Why Are You Interested? - Stocks Register

Dec 10, 2024

Frazier Life Sciences Management L.P. Acquires New Position in Nuvation Bio Inc. (NYSE:NUVB) - MarketBeat

Dec 10, 2024

Dec 09, 2024

MetLife Investment Management LLC Reduces Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World

Dec 09, 2024

Dec 08, 2024

Nuvation Bio (NYSE:NUVB) Shares Gap Down – What’s Next? - Defense World

Dec 08, 2024

Dec 07, 2024

Wexford Capital LP Has $1.49 Million Stock Position in Nuvation Bio Inc. (NYSE:NUVB) - MarketBeat

Dec 07, 2024

Fmr LLC Has $66.96 Million Stake in Nuvation Bio Inc. (NYSE:NUVB) - MarketBeat

Dec 07, 2024

Nuvation Bio (NYSE:NUVB) Shares Gap DownHere's What Happened - MarketBeat

Dec 07, 2024

Nov 26, 2024

Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference - Business Wire

Nov 26, 2024

Nov 20, 2024

Nuvation Bio’s Q3 2024 Highlights and Future Prospects - TipRanks

Nov 20, 2024

Is Nuvation Bio (NYSE:NUVB) Using Debt In A Risky Way? - Simply Wall St

Nov 20, 2024

Nov 16, 2024

Nuvation Bio (NYSE:NUVB) Shares Down 7.7%Time to Sell? - MarketBeat

Nov 16, 2024

Nov 13, 2024

Nuvation Bio's SWOT analysis: taletrectinib drives stock potential amid challenges - Investing.com India

Nov 13, 2024

FMR LLC Bolsters Stake in Nuvation Bio Inc - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

Nuvation Bio to Present at the Jefferies London Healthcare Conference - Business Wire

Nov 12, 2024

Nov 11, 2024

What is Wedbush's Estimate for Nuvation Bio FY2024 Earnings? - MarketBeat

Nov 11, 2024

Nov 08, 2024

Nuvation Bio (NYSE:NUVB) Shares Gap Up After Analyst Upgrade - MarketBeat

Nov 08, 2024

Nuvation Bio’s Global Challenges: Navigating Risks in China Amid Geopolitical Tensions - TipRanks

Nov 08, 2024

Nov 07, 2024

Royal Bank of Canada Increases Nuvation Bio (NYSE:NUVB) Price Target to $6.00 - MarketBeat

Nov 07, 2024

Nuvation Bio reports Q3 EPS (15c, consensus (13c) - TipRanks

Nov 07, 2024

Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update - BioSpace

Nov 07, 2024

Nov 06, 2024